## PGR: Progressive Corporation (The) - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 -1.8% below STRENGTH zone (4.0-10.0%); PEG 4.81 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($217.81)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 2, Bearish: 0)

**1. California Public Employees Retirement System Sells 311,864 Shares of The Progressive Corporation $PGR**
- Source: MarketBeat | 20251207T090842 | Neutral | Relevance: 99%
-  The California Public Employees Retirement System significantly reduced its stake in The Progressive Corporation by selling 311,864 shares, decreasing its holdings by 12.8%. Despite a consensus "Hold" rating and recent price target trims by brokerages, other institutional investors like Vanguard Group Inc. and Geode Capital Management LLC increased their stakes. The company recently missed its quarterly EPS estimates, reporting $4.45 against an expected $5.04.

**2. BMO Capital Adjusts Price Target on Progressive to $256 From $260, Maintains Market Perform Rating**
- Source: marketscreener.com | 20251209T110835 | Neutral | Relevance: 99%
-  BMO Capital has lowered its price target for Progressive (PGR) to $256 from $260, while maintaining a "Market Perform" rating. This adjustment comes amidst other analyst revisions and dividend announcements for the insurance giant. Progressive recently declared a quarterly common share dividend and an annual common share dividend, both payable on January 8, 2026.

**3. Progressive stock price target lowered to $256 by BMO Capital**
- Source: Investing.com | 20251208T183259 | Neutral | Relevance: 99%
-  BMO Capital has decreased its price target for Progressive Corp. (NYSE:PGR) to $256.00 from $260.00, maintaining a Market Perform rating, despite the company trading below its Fair Value according to InvestingPro. This adjustment comes after Progressive declared an annual special dividend of $13.50 per share, which exceeded BMO's and consensus estimates, leading to a reduction in BMO's next-twelve-month buyback projections. The article also notes other recent analyst updates, including UBS maintaining a Neutral rating, Goldman Sachs reiterating a Buy, and Bank of America Securities adjusting its target to $346.00, reflecting varied perspectives on Progressive's financial performance and strategic decisions.

**4. Progressive stock price target lowered to $256 by BMO Capital**
- Source: Investing.com | 20251208T180850 | Neutral | Relevance: 98%
- BMO Capital has reduced its price target for Progressive Corp. (NYSE:PGR) to $256 from $260, while reiterating a Market Perform rating. The adjustment follows Progressive's announcement of an annual special dividend of $13.50 per share, which exceeded BMO's and consensus estimates. This dividend led BMO to lower its next-twelve-month buyback projections to $1.0 billion for fiscal year 2026.

**5. Progressive Corp. price target lowered to $348 by BofA Securities**
- Source: Investing.com UK | 20251208T230915 | Neutral | Relevance: 98%
-  BofA Securities has lowered its price target for Progressive Corp. (NYSE:PGR) to $348.00 from $350.00, while maintaining a Buy rating. This adjustment comes after Progressive announced a $13.50 per share dividend, exceeding BofA's previous forecast and leading the firm to reduce its share repurchase expectations. Despite the lowered target, the insurance company is considered undervalued based on InvestingPro data and has a history of consistent dividend payments.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 4)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | B of A Securiti | $348 | $350 | -1% |
| 2025-12-09 | BMO Capital | $256 | $260 | -2% |
| 2025-11-21 | BMO Capital | $260 | $247 | +5% |
| 2025-11-20 | Wells Fargo | $247 | $246 | +0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | B of A Securiti | main | Buy |
| 2025-12-09 | BMO Capital | main | Market Perform |
| 2025-11-21 | BMO Capital | main | Market Perform |
| 2025-11-20 | Wells Fargo | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 19 ($0.00M) |
| Sells | 7 ($4.16M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.3% (+0.3%)
- Blackrock Inc.: 8.3% (+2.3%)
- JPMORGAN CHASE & CO: 6.2% (+138.6%)
- State Street Corpora: 4.4% (+0.3%)
- Geode Capital Manage: 2.7% (+0.9%)

### Key Risks

1. Insider selling cluster: $4.2M in recent transactions.
2. Valuation stretched: PEG 4.8x requires aggressive growth execution.
3. Long-term trend broken: trading 10.8% below SMA200.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 4.81 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 34%). Balance sheet: strong liquidity (31197000000.0x), $5.1B free cash flow. Analyst sentiment negative (4 target cuts vs 2 raises). Insider selling cluster ($4.2M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $132.7B |
| Beta | 0.36 |
| 52W Range | $199.90 - $292.99 |
| Short Interest | 1.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.81 |
| Forward P/E | 13.9 |
| Current P/E | 12.7 |
| YoY Growth | -8.6% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -0.1% to -1.8% (-1.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.8pp (needs >4.0% for momentum thesis). MRS_5 turning positive (0.3%) - potential reversal signal. Below SMA200 (0.89x), long-term trend not supportive. RSI neutral at 53.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.77% (CS: 47) | Neutral |
| RSI_14 | 53.3 | Neutral |
| MACD Histogram | 0.06 | Bullish |
| vs SMA20 | 1.004x | Above |
| vs SMA50 | 1.004x | Above |
| vs SMA200 | 0.892x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $226.35
- **Stop Loss:** $217.81 (3.8% risk)
- **Target:** $234.89 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 58
- **Position Value:** $13,128.30
- **Portfolio %:** 13.13%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-01-28 (Est: $4.30)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $5.05 | $4.05 | -19.7% |
| 2025Q2 | $4.40 | $4.88 | +10.7% |
| 2025Q1 | $4.75 | $4.65 | -2.1% |
| 2024Q4 | $3.56 | $4.08 | +14.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*